Tag: Jens Kristensen
Calliditas initiates NEFIGARD trial to study Nefecon in Berger’s disease
Nefecon phase 3 trial : Calliditas Therapeutics has initiated a phase 3 clinical trial called NEFIGARD to evaluate its lead candidate Nefecon for the treatment ... Read More